Prime Medicine, Inc.

Equities

PRME

US74168J1016

Market Closed - Nasdaq Other stock markets 06:00:00 18/04/26 am AEST			5-day change	1st Jan Change
3.810 ^USD	+3.81%		+11.08%	+9.80%

17/04	Prime Medicine, Inc. Appoints Svetlana Makhni as Chief Financial Officer	CI
16/04	Prime Medicine Names Svetlana Makhni CFO	MT

Transcript : Prime Medicine, Inc. Presents at TD Cowen 46th Annual Health Care Conference, Mar-04-2026 01

Published on 03/07/2026 at 09:06 am AEDT - Modified on 03/07/2026 at 09:20 am AEDT

S&P Capital IQ

Presenter Speech
Joseph Thome (Analysts)

All right. I think we'll go ahead and get started. Thank you for joining us on day 3 of TD Cowen 46th Annual Healthcare Conference. I'm Joe Thome, one of the

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Latest news about Prime Medicine, Inc.

17/04	Prime Medicine, Inc. Appoints Svetlana Makhni as Chief Financial Officer	CI
16/04	Prime Medicine Names Svetlana Makhni CFO	MT
19/03	Prime Medicine, Inc. Presents at The Citizens Life Sciences Conference 2026, Mar-11-2026 02:15 PM
12/03	Oppenheimer Initiates Prime Medicine at Outperform With $11 Price Target	MT
07/03	Prime Medicine, Inc. Presents at TD Cowen 46th Annual Health Care Conference, Mar-04-2026 01:10 PM
04/03	Prime Medicine, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
04/03	Prime Medicine 2025 Net Loss Narrows as Revenue Rises -- Shares Fall Pre-Bell	MT
04/03	Earnings Flash (PRME) Prime Medicine Posts 2025 Total Revenue $4.6M, vs. FactSet Est of $5.7M	MT
04/03	Earnings Flash (PRME) Prime Medicine Posts 2025 Net Loss $1.35 a Share, vs. FactSet Est of $1.30 Loss	MT
03/03	Prime Medicine, Inc. Auditor Raises 'Going Concern' Doubt	CI
15/01	Prime Medicine, Inc. Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-14-2026 09:00 AM
24/12	LifeSci Initiates Prime Medicine at Outperform With $6 Price Target	MT
22/12	Prime Medicine, Inc.(NasdaqGM:PRME) added to S&P Biotechnology Select Industry Index	CI
20/12	Prime Medicine, Inc. Presents at Evercore 8th Annual Healthcare Conference, Dec-02-2025 11:15 AM
08/12	Prime Medicine Announces the New England Journal of Medicine Publication of Pm359 Clinical Data for the Treatment of Chronic Granulomatous Disease	CI